These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9767278

  • 1. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C, Muramatsu T, Shirai T.
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [Abstract] [Full Text] [Related]

  • 2. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I, Hamm H, Georgi M, Kroiss M, Stolz W, Apitz C, Bröcker EB, Zillikens D.
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [Abstract] [Full Text] [Related]

  • 3. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R, Schmidt E, Chimanovitch I, Leverkus M, Bröcker EB, Zillikens D.
    J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
    [Abstract] [Full Text] [Related]

  • 4. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y, Nishie W, Izumi K, Shimizu H.
    Front Immunol; 2019 Apr; 10():1224. PubMed ID: 31191560
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Amo Y, Ohkawa T, Tatsuta M, Hamada Y, Fujimura T, Katsuoka K, Hashimoto T.
    J Dermatol Sci; 2001 May; 26(1):14-8. PubMed ID: 11323216
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B, Wang C, Chen S, Chen X, Lu X, Tian H, Yu M, Zhang D, Shi Z, Zhou G, Zhang F.
    Indian J Dermatol Venereol Leprol; 2012 May; 78(6):722-7. PubMed ID: 23075641
    [Abstract] [Full Text] [Related]

  • 7. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
    Kromminga A, Sitaru C, Meyer J, Arndt R, Schmidt E, Christophers E, Bröcker EB, Zillikens D.
    J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, Callen JP, Bröcker EB, Diaz LA, Giudice GJ.
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [Abstract] [Full Text] [Related]

  • 9. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
    Murakami H, Amagai M, Higashiyama M, Hashimoto K, Chorzelski TP, Bhogal BS, Jenkins RE, Black MM, Zillikens D, Nishikawa T, Hashimoto T.
    J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
    [Abstract] [Full Text] [Related]

  • 10. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
    Bédane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, Diaz LA, Eady RA, Giudice GJ.
    J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
    [Abstract] [Full Text] [Related]

  • 11. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E, Kromminga A, Mimietz S, Leinfelder U, Sitaru C, Bröcker EB, Zillikens D, Zimmermann U.
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [Abstract] [Full Text] [Related]

  • 12. Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.
    Fairley JA, Bream M, Fullenkamp C, Syrbu S, Chen M, Messingham KN.
    J Am Acad Dermatol; 2013 Mar; 68(3):395-403. PubMed ID: 23083837
    [Abstract] [Full Text] [Related]

  • 13. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Bröcker EB, Yancey KB, Zillikens D.
    Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
    [Abstract] [Full Text] [Related]

  • 14. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
    Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, Imamura K, Okamoto E, Yasumoto S, Hashimoto T.
    J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
    [Abstract] [Full Text] [Related]

  • 15. Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180.
    Lee JB, Liu Y, Hashimoto T.
    J Dermatol Sci; 2003 Jun; 32(1):59-64. PubMed ID: 12788530
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D, Herzele K, Georgi M, Schmidt E, Chimanovitch I, Schumann H, Mascaro JM, Diaz LA, Bruckner-Tuderman L, Bröcker EB, Giudice GJ.
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [Abstract] [Full Text] [Related]

  • 17. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen.
    Matsumura K, Amagai M, Nishikawa T, Hashimoto T.
    Arch Dermatol Res; 1996 Aug; 288(9):507-9. PubMed ID: 8874743
    [Abstract] [Full Text] [Related]

  • 18. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F, Grosso F, Terracina M, Ruffelli M, Cordiali-Fei P, Sera F, Zambruno G, Mastrogiacomo A, Di Zenzo G.
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
    Zillikens D.
    Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.